Elemental Impurities | Quality Assistance

This study sheet outlines regulatory requirements, risk assessment approaches and analytical methods for elemental impurities according to ICH Q3D and USP <232>. It describes three validated ICP‑MS methods suitable for various pharmaceutical matrices and provides guidance for compliance of drug products, APIs and excipients.

Explore our full capabilities for elemental impurities assessment

Discover more

Download file

Complete this form and access this document in seconds.

Name

First Name

Last Name

Email Address

Company / Organisation

Address

Country

Opt-in

I have read and accept the General Conditions. More info about Terms of Use and Privacy Policy.

We would like to obtain your consent to use your personal data for the following purposes:

Necessary Toggle: These cookies are required for the proper functioning of our website and cannot be disabled in our system.
Learn more
Performance Toggle: We use these cookies to provide statistical information about our website. They are used for performance measurement and improvement.
Learn more
Functional Toggle: These cookies are used to improve the functionality of our website and to allow you to personalize features like live chats, videos and use of social media.
Learn more
Advertising Toggle: These cookies are installed on our site by our advertising partners.
Learn more